Live website intelligence
Weight Management for Adults with Obesity | Wegovy® (semaglutide)
Wegovy<sup>®</sup> (semaglutide) injection 2.4 mg or tablets 25 mg for adults with obesity. See how Wegovy® supports weight loss with guidance, dosing information and savings resources to help you get started. Read important safety and prescribing info, including boxed warning.
Last refresh
Updated 57d ago
Analyst read
Professional
Detected stack
Quick read
How to read wegovy.com quickly
wegovy.com looks like health & fitness. Traffic estimates are limited, so use the trust and structure modules first. Current AI trust scoring is 15/100.
What to do next
- The stack appears to include React.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
34/56 fields populated (61%)
Providers with missing fields
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 0/5
Missing: isAdvertiser, advertiserIds, advertiserNames, resultCount, transparencySignals
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 0/10
Missing: monthlyVisits, globalRank, countryRank, bounceRate, avgVisitDuration, pagesPerVisit, topCountry, topRegions, topKeywords, trafficSources
whois: 6/6
All expected fields present
radar: 0/4
Missing: globalRank, rankBucket, categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
Wegovy is a prescription weight management medication (semaglutide) manufactured by Novo Nordisk, marketed to adults with obesity as an adjunct to diet and exercise. The website serves as a patient-facing hub for product information, dosing guidance, savings programs, and treatment initiation resources.
Classification
Trust & Risk
Trust Assessment
Publisher Monetization
Monetization Signals
AI Visual Analysis
IAB Taxonomy
Business Insights
Business Model
Pharmaceutical/Biotech - Prescription Drug Marketing model detected
Trust Level
Low trust with 15/100 score
Audience
Adults with obesity (BMI ≥30 or ≥27 with weight-related comorbidities), healthcare providers prescribing weight management treatments, and caregivers supporting patients with chronic weight conditions
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.